Alan So

Dr. Alan So is a research scientist at the Vancouver Prostate Centre and associate professor in the Department of Urologic Sciences at the University of British Columbia. His current research focuses on the development of novel therapeutics for bladder cancer and determination of the functional role of GLI1/2 in the progression of prostate cancer to its lethal stage of androgen independence. He has characterized the functional role of different survival genes (including clusterin and Hsp27) in different tumor models in cancer progression.